Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
P-fimbriae, also known as pyelonephritis-associated pili (Pap), are filamentous surface appendages found on uropathogenic Escherichia coli (UPEC) that play a critical role in the pathogenesis of upper urinary tract infections [Wikipedia]. These structures are assembled via the chaperone-usher pathway and consist of a major pilin rod (PapA) and a distal tip complex containing the PapG adhesin [NIH, 1.3.2]. PapG specifically recognizes and binds to Gal(alpha1-4)Gal-containing glycosphingolipids (globoseries) on the surface of host uroepithelial cells, particularly in the kidneys [NIH, 1.3.1]. This adherence is essential for bacterial colonization, resistance to the flushing action of urine, and the induction of a robust inflammatory response that contributes to tissue damage in pyelonephritis [NIH, 1.3.5]. Therapeutic strategies targeting P-fimbriae include the use of galabiose-based anti-adhesion agents, pilicides that disrupt pilus assembly, and vaccines designed to elicit protective antibodies against the fimbrial subunits [NIH, 1.2.1, 1.2.2].
Inhibition of bacterial adhesion to host uroepithelial cells by competitive binding to Gal(alpha1-4)Gal receptors and disruption of the chaperone-usher assembly pathway for pilus formation [NIH, 1.2.1, 1.2.2].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on P-fimbriae of uropathogenic Escherichia coli (Pap).